LPS induces greater bone and PDL loss in SPARC-null mice

Area of Science:

• Periodontology
• Biomaterials Science
• Extracellular Matrix Biology

Background:

• Periodontal disease increases tooth loss risk, often linked to alveolar bone and periodontal ligament (PDL) damage.
• Current treatments lack predictable regeneration of damaged PDL.
• Collagen I is crucial for bone and PDL extracellular matrix, and SPARC/Osteonectin (SP/ON) regulates its content.

Purpose of the Study:

• To investigate the role of SPARC/Osteonectin (SP/ON) in experimental periodontal disease.
• To determine if SP/ON deficiency affects collagen content and tissue integrity in the PDL and alveolar bone.

Main Methods:

• Periodontal disease was induced using lipopolysaccharide (LPS) in wild-type and SP/ON-null mice.
• Mice received LPS injections between molars over four weeks, with PBS controls.
• Bone volume, PDL connective tissue, cell numbers, inflammatory infiltrate, and collagen fiber structure were analyzed.

Main Results:

• LPS injection significantly decreased bone volume in both genotypes, with greater loss in SP/ON-null mice.
• SP/ON-null PDL showed more connective tissue degradation and reduced collagen volume fraction.
• Despite similar cell numbers, SP/ON-null PDL had reduced inflammatory infiltrate.

Conclusions:

• SPARC/Osteonectin (SP/ON) protects collagen content in the periodontal ligament (PDL) and alveolar bone during experimental periodontal disease.
• SP/ON deficiency exacerbates bone loss and connective tissue damage in periodontal disease.
• These findings highlight SP/ON's potential therapeutic role in periodontal regeneration.